
Drug Updates
New Drugs
New Indications
Patient Teaching

News Capsules

Drug Warnings

Herbal Spotlight

Quik Tools

Drug Info
Links

Drug Info Bookstore

Feedback

Registration

Disclaimer

|

|

antihemophilic factor/von Willebrand factor complex (human), dried, pasteurized |
| Humate-P |
Pharmaceutical
company:
CSL Behring www.cslbehring.com |
NEW INDICATION & DOSAGE
Prevention of surgical bleeding in patients with mild to moderate and severe von Willebrand disease--
Adults and children: For emergency surgery, 50 to 60 international units/kg I.V. For non-emergency surgery, calculate loading dose:
target peak plasma von Willebrand factor:ristocetin cofactor (VWF:RCo) - baseline plasma VWF:RCo × body weight (kg) ÷ by incremental in vivo recovery (known as IVR) = required VWF:RCo factor (in international units).
Give 2 hours before surgery and then every 8 to 12 hours for up to 3 days postoperatively. Base maintenance dose on patient response and plasma VWF:RCo factor levels.
|